Monitoring inflammation in IBD with wearable sensors
Part of Digestive system clinical trials.
This study is testing a new way to check inflammation in people with active IBD using non-invasive devices (like a smartwatch or sensor). It aims to find a simpler method than blood tests or stool samples, which could help manage your condition more easily.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be at least 18 years old.
- You must have a diagnosis of inflammatory bowel disease (IBD), which includes Crohn's disease or ulcerative colitis.
- Your IBD must be active right now – meaning you have symptoms like diarrhea or tummy pain, and tests (like stool or blood tests) show inflammation.
- You need to have a smartphone (iPhone or Android) with internet access to participate.
- You cannot be pregnant.
- You cannot have a pacemaker or other implanted electronic device, and you must not be allergic to steel or rubber.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether digital tools, like a smartphone app and a wearable activity tracker, can help monitor your inflammatory bowel disease (IBD). You would use these tools and answer questionnaires to help doctors better understand your condition.
This study tests whether data from your own smartwatch or smartphone can help detect when your Crohn's disease or ulcerative colitis flares up. If you join, you'll use your own device, and no extra equipment will be provided.
This trial tests a smart pill that measures gut health in people with colon inflammation (ulcerative colitis) or colon cancer. It aims to see if the pill can help doctors better understand how the gut is working during treatment or before surgery.
This trial tests if regular video check-ins via phone or computer can help people with IBD stick to their medications and feel better emotionally. You would use a messaging app and video calls to stay in touch with your care team from home.
This study follows people with inflammatory bowel disease (Crohn's disease or ulcerative colitis) who may be taking immunosuppressants (medicines that calm the immune system). Researchers will track how the disease progresses and look at factors like gut bacteria to find ways to predict complications.
This study tests whether a smartphone app called SMART IBD can help children with IBD take their medications more consistently. It is for children who are currently missing more than 1 in 7 doses of their daily or weekly IBD medication.
Hear when a new Inflammatory Bowel Disease (IBD) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.